Fresenius Kabi Deutschland GmbH

Tweet this page
<
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 26 May 2021
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

75,000€

Financial year: Jan 2019 - Dec 2019

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

1

Lobbying Costs over the years

  • Info

    Fresenius Kabi Deutschland GmbH

    EU Transparency Register

    130305227617-65 First registered on 29 Jun 2017

    Goals / Remit

    Fresenius Kabi is a global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. Our products and services are used to help care for critically and chronically ill patients. In Europe, Fresenius Kabi is the market leader in infusion therapy and clinical nutrition
    Fresenius Kabi employs about 39,000 people worldwide. With our corporate philosophy "caring for life", we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face. Further we are committed to improving patients' quality of life wherever needed: whether in hospitals, medical centres or at patient's homes.
    Fresenius Kabi AG is a wholly owned subsidiary of the Fresenius SE & Co. KGaA healthcare group.

    Main EU files targeted

    Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical and Biosimilars legislation, EU Trade Policy, European external trade agenda, Pharmaceuticals in the environment, global health.

    Address

    Head Office
    Fresenius Kabi Deutschland GmbH
    Else-Kröner-Str. 1
    Bad Homburg 61352
    GERMANY
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 26 May 2021

    Name Start date End Date
    Mr Matthew TURNER 11 Feb 2023 11 Feb 2024
    Mr Stefan KOLB 20 Jan 2023 20 Jan 2024
    Mr Hrishikesh KULKARNI 24 Mar 2022 24 Mar 2023
    Mr Matthew TURNER 05 Nov 2019 31 Oct 2020
    Mr Stefan KOLB 10 Oct 2019 01 Nov 2020
    Mr David M JAUCH 23 Oct 2018 23 Oct 2019

    Complementary Information

    Other persons are involved, but less than 25%.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    Medicines for Europe, Medical Nutrition International

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2019 - Dec 2019

    Lobbying costs for closed financial year

    75,000€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    None

    Other activities

    Fresenius Kabi is cooperating with the institutions of the European Union to support policies that improves patient access to affordable medicines.

  • Meetings

    Meetings

    1 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard